308 related articles for article (PubMed ID: 37349696)
21. Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Noro D; Koie T; Hashimoto Y; Tanaka T; Ohyama C; Tobisawa Y; Yoneyama T; Imai A; Hatakeyama S; Yamamoto H; Kitayama M; Hirota K
Jpn J Clin Oncol; 2018 Feb; 48(2):184-189. PubMed ID: 29177431
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study.
Ślusarczyk A; Zapała P; Zapała Ł; Rajwa P; Moschini M; Laukhtina E; Radziszewski P
Urol Oncol; 2024 Jan; 42(1):22.e1-22.e11. PubMed ID: 37981503
[TBL] [Abstract][Full Text] [Related]
23. Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.
Kobayashi S; Ito M; Takemura K; Suzuki H; Yonese I; Koga F
Int J Clin Oncol; 2022 Mar; 27(3):574-584. PubMed ID: 34860315
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
25. Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.
Ye J; Zheng L; Chen Z; Wang Q; Liao X; Wang X; Wei Q; Bao Y
BMC Urol; 2024 Mar; 24(1):62. PubMed ID: 38509518
[TBL] [Abstract][Full Text] [Related]
26. Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study.
Tian C; Liu J; An L; Hong Y; Xu Q
BMC Urol; 2023 Jan; 23(1):2. PubMed ID: 36609283
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma.
von Deimling M; D'Andrea D; Pradere B; Laukhtina E; Yanagisawa T; Kawada T; Majdoub M; Rajwa P; Pallauf M; Singla N; Soria F; Margulis V; Chlosta P; Karakiewicz PI; Roupret M; Teoh JY; Fisch M; Rink M; Moschini M; Lotan Y; Shariat SF
World J Urol; 2023 Jul; 41(7):1861-1868. PubMed ID: 37294372
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.
Hou G; Zheng Y; Zhang L; Lai D; Wang F; Li X; Yan F; Tian J; Zhang G; Meng P; Wei D; Zhu Z; Yuan J; Hui Q; Yuan J
World J Urol; 2020 Aug; 38(8):1969-1975. PubMed ID: 31654221
[TBL] [Abstract][Full Text] [Related]
29. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
30. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
31. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
[TBL] [Abstract][Full Text] [Related]
34. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
35. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
36. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Model for Predicting Intravesical Recurrence in Organ-confined Upper Urinary Tract Urothelial Carcinoma Patients after Radical Nephroureterectomy: a Retrospective Study in One Center with Long-term Follow-up.
Zhang X; Bu R; Liu Z; Wu B; Bai S
Pathol Oncol Res; 2020 Jul; 26(3):1741-1748. PubMed ID: 31643022
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
39. A novel nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Luo Z; Jiao B; Yan Y; Liu Y; Chen H; Guan Y; Ding Z; Zhang G
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14241-14253. PubMed ID: 37555950
[TBL] [Abstract][Full Text] [Related]
40. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
